Mark Rubinstein to Programmed Cell Death 1 Receptor
This is a "connection" page, showing publications Mark Rubinstein has written about Programmed Cell Death 1 Receptor.
Connection Strength
0.374
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
Score: 0.184
-
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. Cancer. 2018 04 15; 124(8):1650-1659.
Score: 0.141
-
Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model. PLoS One. 2022; 17(9):e0273076.
Score: 0.049